Search results
Heart Failure in Primary Care
Author(s):
Loreena Hill
,
Anne McNulty
,
James McMahon
,
et al
Added:
1 year ago
Article
Author(s):
Ahmad Masri
,
Added:
1 year ago
Recorded during HFA 2024, Dr Caroline Coats, Glasgow University, UK, and Dr Ahmad Masri, Oregon Health and Science University, US, collaborate to explore the pivotal advancements in managing hypertrophic cardiomyopathy unveiled at the conference.This programme is thoughtfully divided into four chapters, facilitating a smooth journey through the latest HCM trial data, including a comprehensive…
View more
Author(s):
Anna Meta Dyrvig Kristensen
Added:
1 day ago
AHA Scientific Sessions 2025 – Dr Anna Meta Dyrvig Kristensen (Copenhagen University Hospital, Bispebjerg and Frederiksberg, DK) presents an individual patient data meta-analysis examining beta-blocker therapy after myocardial infarction in patients with preserved left ventricular ejection fraction.This comprehensive meta-analysis pooled individual patient data from five randomized controlled…
View more
Author(s):
Mohammed El-Sheikh
,
Nora Olsen El Caidi
,
Aginsha Kandiah
,
et al
Added:
3 weeks ago
Author(s):
Georgios Koukoulitsios
,
Kyriaki Tsikritsaki
,
Georgios Magklaras
,
et al
Added:
5 months ago
Implementing HF Guidelines with Collaborative Care
Video Series
Start date:
Aug 27, 2023
End date:
Aug 27, 2023
Radcliffe Medical Education present a satellite symposium entitled ‘Implementing Heart Failure Guidelines with Collaborative Care’ at the ESC Congress 2023 in Amsterdam, NL. Join us in the Riga Lecture Room, or online, on Sunday 27 August 2023, from 12:45 to 13:45 CEST.
This session, chaired by Prof Carolyn Lam (National Heart Centre Singapore, SG), provides an excellent opportunity for…
View more
Author(s):
Karol Mirkowski
,
Ercole Vellone
,
Bernadetta Żółkowska
,
et al
Added:
8 months ago
Author(s):
Erin A Bohula
,
Harriette Van Spall
Added:
9 hours ago
AHA Scientific Sessions 2025 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Erin A Bohula (Brigham & Women's Hospital, US) to discuss the primary results of the VESALIUS-CV trial, a large-scale, phase 3, double-blind, randomised, placebo-controlled study sponsored by Amgen.The VESALIUS-CV trial (NCT03872401) evaluated the impact of evolocumab, a PCSK9…
View more
Author(s):
Ahmad Jabri
,
Anas Alameh
,
Gennaro Giustino
,
et al
Added:
1 year ago
